What ALIMERA SCIENCES INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director | Sep 16 | Disposition to Issuer · D | −4,178,725 | — | — | 0 |
| Morgan Adam | Director | Sep 16 | Disposition to Issuer · D | −9,429,808 | — | — | 0 |
| Caligan Partners Lp | 10% owner | Sep 16 | Other Transaction · J | −16,835,154 | — | — | 0 |
| Ashman Philip | President of Int'l Operations | Sep 16 | Disposition to Issuer · D | −118,274 | — | — | 0 |
| Pizzo Peter J. Iii | Director | Sep 16 | Disposition to Issuer · D | −500 | — | — | 0 |
| Werner Jason M. | Chief Operating Officer | Sep 16 | Disposition to Issuer · D | −225,000 | — | — | 225,000 |
| Eiswirth Richard S Jr | President and CEO | Sep 16 | Disposition to Issuer · D | −324,018 | — | — | 0 |
| Snisarenko John | Director | Sep 16 | Disposition to Issuer · D | −10,000 | — | — | 0 |
| Holland David | Chief Marketing Officer & SVP | Sep 16 | Disposition to Issuer · D | −187,756 | — | — | 0 |
| Ashman Philip | President of Int'l Operations | Mar 26 | Withheld — tax / exercise cost · F | −12,103 | $3.83 | −$46.4K | 118,274 |
| Ashman Philip | President of Int'l Operations | Jan 10 | Withheld — tax / exercise cost · F | −2,938 | $3.86 | −$11.3K | 130,377 |
| Eiswirth Richard S Jr | President and CEO | Oct 02 | Grant / award · A | +400,000 | — | — | 722,518 |
| Werner Jason M. | Chief Operating Officer | Oct 02 | Grant / award · A | +225,000 | — | — | 225,000 |
| Caligan Partners Lp | 10% owner | Sep 14 | Open-market buy · P | +579,000 | $3.39 | +$1.96M | 16,835,154 |
| Caligan Partners Lp | 10% owner | Sep 14 | Open-market sale · S | −579,000 | $3.39 | −$1.96M | 16,256,154 |
| Morgan Adam | Director | Aug 15 | Derivative Conversion · C | +4,178,725 | $1.70 | +$7.1M | 4,178,725 |
| Morgan Adam | Director | Aug 15 | Derivative Conversion · C | +2,924,762 | $2.10 | +$6.14M | 9,429,808 |
| Morgan Adam | Director | Aug 15 | Derivative Conversion · C | +4,845,392 | $1.70 | +$8.24M | 6,505,046 |
| Caligan Partners Lp | 10% owner | Aug 15 | Derivative Conversion · C | +13,431,616 | $1.70 | +$22.8M | 16,835,154 |
| Caligan Partners Lp | 10% owner | Aug 15 | Derivative Conversion · C | +2,924,761 | $2.10 | +$6.14M | 3,403,538 |
Loading...
